BG60697B2 - Medicamentous form having continous release based on ethodolacquer - Google Patents

Medicamentous form having continous release based on ethodolacquer

Info

Publication number
BG60697B2
BG60697B2 BG96617A BG9661792A BG60697B2 BG 60697 B2 BG60697 B2 BG 60697B2 BG 96617 A BG96617 A BG 96617A BG 9661792 A BG9661792 A BG 9661792A BG 60697 B2 BG60697 B2 BG 60697B2
Authority
BG
Bulgaria
Prior art keywords
ethodolacquer
release based
medicamentous form
continous
hydroxypropylmethylcellulose
Prior art date
Application number
BG96617A
Other languages
Bulgarian (bg)
Inventor
John Michelucci
Deborah Sherman
Richard Deneale
Original Assignee
American Home Products Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/268,646 external-priority patent/US4966768A/en
Application filed by American Home Products Corp. filed Critical American Home Products Corp.
Publication of BG60697B2 publication Critical patent/BG60697B2/en

Links

Abstract

Лекарствената форма намира приложение като аналгетично и противовъзпалително средство. Тя представлява таблетка, съдържаща компонентите 1,2-диетил-1,3,4,9-тетрахидропиранол /3,4/ индол-1-оцетна киселина (етодолак), хидроксипропилметилцелулоза, етилцелулоза и освобождаващ агент, например двуосновен натриев фосфат. Хидроксипропилметилцелулозата съдържа хидроксипропил от 7,0 до 8,6% тегл.The drug form is used as an analgesic and anti-inflammatory agent. It is a tablet comprising 1,2-diethyl-1,3,4,9-tetrahydropyranol (3,4) indole-1-acetic acid (etodolac), hydroxypropylmethylcellulose, ethylcellulose and a release agent, for example dibasic sodium phosphate. Hydroxypropylmethylcellulose contains hydroxypropyl from 7.0 to 8.6% by weight.

BG96617A 1988-11-07 1992-07-15 Medicamentous form having continous release based on ethodolacquer BG60697B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/268,646 US4966768A (en) 1987-09-24 1988-11-07 Sustained release etodolac

Publications (1)

Publication Number Publication Date
BG60697B2 true BG60697B2 (en) 1995-12-29

Family

ID=23023894

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96617A BG60697B2 (en) 1988-11-07 1992-07-15 Medicamentous form having continous release based on ethodolacquer

Country Status (1)

Country Link
BG (1) BG60697B2 (en)

Similar Documents

Publication Publication Date Title
DK531088A (en) PHARMACEUTICAL PREPARATIONS OF 1,8-DIETHYL-1,3,4,9-TETRAHYDROPYRANO 3,4-B-INDOL-1-ACETIC ACID OR SALTS THEREOF
MY103212A (en) Zinc-protamine-alpha interferon complex
SE8406081D0 (en) METHOD AND COMPOSITION FOR THE PREPARATION OF CONTROLLED LONG-ACTING PHARMACEUTICALS FOR ORAL ADMINISTRATION
FI883785A (en) CAPSULE FOER PHARMACEUTICAL VERKSAMT INHALERING SEED I ETT CEILINGS.
NO175620C (en) Process for the preparation of an antitumor drug
DK74187D0 (en) PREPARATION FOR SLOW RELEASE AND PROCEDURES FOR PRODUCING THEREOF
SE8800731L (en) phenylcarbamate
ATE100708T1 (en) UNCOATED PHARMACEUTICAL REACTION TABLET.
FR2613224B1 (en) EXTENDED RELEASE BILAYER DOSAGE FORM
IS1565B (en) Process for the preparation of N1-substituted benzimidazole derivatives for therapeutic use
SE8803221D0 (en) WATER SOLUBLE MONOESTERS AS SOLUBILIZERS FOR PHARMACOLOGICALLY ACTIVE COMPOUNDS AND PHARMACEUTICAL EXCIPIENTS
FI920957A0 (en) EN DOSERINGSFORM FOER TILLFOERSEL AV LOESLIGA ELLER OLOESLIGA CEAKEMEDEL.
ES2059625T3 (en) A PROCEDURE FOR PREPARING A HYDROXIALKYLCHYSTEINE DERIVATIVE.
NL175882C (en) PHARMACEUTICAL PREPARATION CONTAINING AN ANTI-INFLAMMATORY COMPOUND.
LV10949A (en) Substituted 4-Phenyl-4-piperidinecarboxamide Compound for Pharmaceutical Formulation
DK77588A (en) PROSTAGLANDIN E1 DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
BG60697B2 (en) Medicamentous form having continous release based on ethodolacquer
DK229089D0 (en) PEPTID-PHARMACEUTICAL PREPARATIONS CONTAINING ALFA-AMINOBORIC ACID DERIVATIVES FOR ADMINISTRATION BY THE MICE
AU4807990A (en) Antinephrotoxic perfusion solution
DE3778165D1 (en)
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
RU97120428A (en) METHOD FOR SIMULATING HYPOTHYROIDISM
ES458413A1 (en) Pharmaceutical composition
JPS52136923A (en) Method of combatting pancreatic necrosis of fishes
DK493887A (en) BUCCAL FORMULATION